The progressive aging of the population and the growing demand for a better quality of life make it essential to treat degenerative or post-traumatic pathologies effectively in their early stages, in order to avoid or postpone prosthetic surgery or spinal stabilization.
Clover Next has developed various regenerative medicine methods that combine efficacy, ease of use, and sustainability, serving as a concrete and effective alternative to current conservative and pharmacological therapies.
In the early stages, biomaterials and autologous therapies are utilized. For more severe conditions, treatment may include prosthetics and spinal fixation, always ensuring the most effective and appropriate solution for every patient.
Up to the age of 60, the body maintains strong self-healing abilities, and biomaterials and autologous therapies can effectively treat post-traumatic and degenerative conditions, relieving pain. After 60, these abilities decline, and treatments become primarily aimed at pain relief or delaying major surgical procedures. In severe cases, prosthetic replacement or spinal arthrodesis becomes necessary.
A patient who leads an active life and shows strong determination will certainly achieve better outcomes with regenerative medicine techniques. A sedentary patient with no specific functional demands is often less motivated and should be managed progressively.
Thanks to a comprehensive range of medical devices, Next enables professionals and patients to access care pathways dedicated to various musculoskeletal and connective tissue disorders.
Our treatment guidelines take into account the severity of the condition, the patient’s age, and lifestyle.
In the early stages, biomaterials and autologous therapies are used. For more severe conditions, treatment may include prosthetics and spinal fixation, always ensuring the most effective and appropriate solution for each patient.
